Carregant...
Clinical trials for BET inhibitors run ahead of the science
Several cancer clinical trials for small molecule inhibitors of BET bromodomain proteins have been initiated. There is enthusiasm for the anti-proliferative effect of inhibiting BRD4, one of the targets of these inhibitors, which is thought to cooperate with MYC, a long-desired target for cancer the...
Guardat en:
| Publicat a: | Drug Discov Today Technol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5116321/ https://ncbi.nlm.nih.gov/pubmed/27769357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ddtec.2016.06.004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|